• Latest Posts

AstraZeneca and Daiichi Sankyo’s Enhertu recommended for approval

Mablink Bioscience receives €31M series A funding for ADC pipeline 

Trial starts for treatment of warm autoimmune hemolytic anemia

Araris Biotech closes $24M financing round for ADCs

Pheon Therapeutics launches with $68M in series A funding for treatment of solid tumors

Startup Scout 22 Sep 2022

Cartography Biosciences unearths cancer immunotherapy targets


Synaffix and Emergence in $360M technology platform deal to develop ADCs

CSL gets positive results for preventive treatment in patients with hereditary angioedema

Mersana Therapeutics announces collaboration with GSK for the co-development of cancer treatment

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Patients with advanced cancer set to benefit from ProfoundBio’s new drug

Boston startup bags $40M Series A to smash preclinical bottlenecks